Finance

Beta
Lists
PFRM3:BVMF
Profarma Distribuidora de Produts Frm SA
R$6.62
-1.34%
(-0.090) 1D
Jun 5, 4:44:53 PM GMT-3  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for PFRM3...
Open
R$6.69
High
R$6.77
Low
R$6.60
Mkt. cap
828.05M
Avg. vol.
235.59K
Volume
104.40K
Dividend
9.32%
Quarterly dividend
R$0.15
Ex-dividend date
Dec 1, 2025
P/E ratio
7.70
52-wk high
R$9.70
52-wk low
R$6.14
EPS
R$0.86
Shares outstanding
123.81M
No. of employees
7K
Open
R$6.69
High
R$6.77
Low
R$6.60
Mkt. cap
828.05M
Avg. vol.
235.59K
Volume
104.40K
Dividend
9.32%
Quarterly dividend
R$0.15
Ex-dividend date
Dec 1, 2025
P/E ratio
7.70
52-wk high
R$9.70
52-wk low
R$6.14
EPS
R$0.86
Shares outstanding
123.81M
No. of employees
7K
News stories
From sources across the web
About Profarma Distribuidora de Produts Frm SA
CEOSammy Birmarcker
Employees7.08K
Founded1961
Headquarters-
SectorHealth care provider
Websiteprofarma.com.br
Previous reportsAll values in BRL
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in BRL
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
2.70B
2.85B
3.19B
2.87B
Cost of goods sold
2.27B
2.40B
2.71B
2.44B
Cost of revenue
2.27B
2.40B
2.71B
2.44B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
336.20M
326.17M
364.01M
375.35M
Operating expense
341.80M
342.47M
370.96M
378.54M
Total operating expenses
2.61B
2.75B
3.08B
2.82B
Operating income
92.18M
104.56M
104.32M
55.87M
Other non operating income
-11.43M
-12.26M
-13.12M
-10.34M
EBT including unusual items
30.00M
43.77M
43.72M
-7.44M
EBT excluding unusual items
30.00M
43.77M
43.72M
-7.44M
Income tax expense
6.51M
-5.30M
1.97M
-6.17M
Effective tax rate
21.70%
-12.12%
4.52%
82.91%
Other operating expenses
5.59M
16.30M
6.96M
3.18M
Net income
21.77M
46.68M
38.78M
-1.75M
Net profit margin
0.81%
1.64%
1.22%
-0.06%
Earnings per share
-
-
-
-
Interest and investment income
2.79M
7.11M
2.37M
757.00K
Interest expense
-53.51M
-55.59M
-49.80M
-53.75M
Net interest expenses
-50.72M
-48.49M
-47.43M
-53.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
105.10M
118.34M
119.57M
71.74M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer